乳糖对帕金森病患者便秘的影响:一项探索性试点研究
Shin-Ichiro Kubo1, Mako Ito2, Kyoko Matsuba2
1Parkinson's Disease Center, Department of Neurology, Eisei Clinic, 588-17 Kunugidamachi, Hachioji, Tokyo 193-0942, Japan.
eNeurologicalSci
|May 23, 2024
概括
乳酪糖显著改善了帕金森病 (PD) 患有便秘的患者的肠道运动和便的一致性. 这项试点研究表明,乳糖是PD相关便秘的安全有效治疗选择.
科学领域:
- 神经学 神经学
- 胃肠病学 胃肠病学
背景情况:
- 便秘是帕金森病 (PD) 的一个普遍的非运动性症状.
- 与PD相关的便秘显著降低了患者的生活质量.
研究的目的:
- 评估乳糖在治疗帕金森病患者便秘方面的疗效.
- 评估乳糖对排便模式和便一致性的影响.
主要方法:
- 一项开放标签,单中心试点研究,涉及29名帕金森病患者.
- 患者接受了三周的乳糖治疗,评估了自发性肠道排便 (SBM),便一致性 (布里斯托尔便形式量表 (BSFS)) 和救援松剂的使用.
主要成果:
- 与干预前期相比,在乳糖治疗期间观察到SBM数量的显著增加.
- 患者表现出改善的便一致性 (更高的BSFS得分) 和显著减少救援药的使用.
- 乳酪糖耐受性良好,没有报告严重不良事件.
结论:
- 乳酪糖显示出作为帕金森病中便秘的有效治疗潜力.
- 需要进一步的随机对照试验来证实这些发现,并制定最终的治疗指南.
相关概念视频
Parkinson's Disease: Treatment
261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261
Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Drugs for Treatment of Diarrhea-Predominant IBS
160
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
160
Parkinson's Disease: Overview
528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
73
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
73


